When was SmartHealth founded?

SmartHealth was founded in 1979 and raised its 1st funding round 44 years after it was founded.

Where is SmartHealth located?

SmartHealth is headquartered in Irvine, United States.

Who is the current CEO of SmartHealth?

Matthew Nunez and Larry Dentice s of SmartHealth.

How many employees does SmartHealth have?

As of May 31, 2026, the latest employee count at SmartHealth is 10.

Is SmartHealth a funded company?

SmartHealth is a funded company, having raised a total of $17.3M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Mar 24, 2023.

When was the latest funding round of SmartHealth?

SmartHealth's latest funding was a $***** Series B round on Nov 15, 2024, with participation from 0 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $2.26B in funding in 2026 to date.

Where does SmartHealth rank among its competitors?

SmartHealth ranks 56th amongst 606 active competitors, of which 158 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Delfi Diagnostics, which secured $34.3M in Dec, 2025.

Who are the top competitors of SmartHealth?

SmartHealth's top competitors include Guardant Health, Natera and Myriad Genetics. Among them, Delfi Diagnostics secured the most recent funding round in December, 2025.

SmartHealth - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer precision diagnostics for vascular, metabolic, and oncological diseases. The company offer SmartPath Dx and SmartVascular Dx for diagnosing vascular inflammation and pathology. Other products include SmartLung Dx and SmartKidney Dx to detect lung cancer and kidney diseases.

Website: smarthealthdx.com
Social
Email ID: *****@smarthealthdx.com
Phone Number: +1 **********

Key Metrics

Founded Year

1979

Location

Irvine, United States

Stage

Series B

Total Funding

$17.3M in 3 rounds

Latest Funding Round

Series B, Nov 15, 2024, $*****

Ranked

56^th among 606 active competitors

Employee Count

10 as on May 31, 2026

Similar Companies

Guardant Health & 743 more

View SmartHealth's full profile

SmartHealth has raised a total funding of $17.3M over 3 rounds. Its first funding round was on Mar 24, 2023.

Here is the list of recent funding rounds of SmartHealth:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 15, 2024	4176196	Series B	1278083	7743926	8955034	1484873
Aug 14, 2024	1341312	Series B	6822253	4711432	6050911	9827644
Mar 24, 2023	3081087	Series B	2413271	3687408	1634045	8956577

Access funding benchmarks and valuations. Sign up today!

View details of SmartHealth's funding rounds and investors

SmartHealth's employee count trend

SmartHealth has 10 employees as of May 26. Here is SmartHealth's employee count trend over the years:

Uncover SmartHealth's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SmartHealth include Guardant Health, Natera and Myriad Genetics. Here is the list of Top 10 competitors of SmartHealth, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	Lightspeed Venture Partners, Orbimed & 25 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Foresite Capital & 17 others	77/100
3rd	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, New Venturetec & 6 others	72/100
4th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Google Ventures & 11 others	71/100
5th	Exact Sciences 1995, Madison (United States), Acquired	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Back Bay Group & 8 others	71/100
6th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Braidwell & 19 others	71/100
7th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
8th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	69/100
9th	Delfi Diagnostics 2019, Baltimore (United States), Series B	Provider of DNA sequencing for cancer detection	$332M	Merck Global Health Innovation Fund, DFJ Growth ... & 19 others	68/100
10th	Foresight Diagnostics 2020, Aurora (United States), Acquired	Developer of minimally-invasive liquid biopsy test for the detection of cancer	$104M	Foresite Capital, Civilization Ventures & 6 others	66/100
56th	SmartHealth 1979, Irvine (United States), Series B	Developer precision diagnostics for vascular, metabolic, and oncological diseases	$17.3M	-	49/100